Opmed.ai

• If procurement requires extensive third-party review coverage as a primary selection criterion: public review density for this product is limited.
• If procurement requires publicly posted security attestations (e.g., a published SOC 2 Type II report): such attestations were not found in the public materials reviewed.
• If the organization prefers a vendor with widely published large-scale deployments and collateral: some competitors disclose broader adoption metrics and case studies.
• If the priority is workflow automation for non-scheduling tasks (documents, PAT coordination) rather than schedule optimization: other vendors may offer more mature workflow automation modules.
• If there are concerns about execution risk related to early-stage vendors: public employee-sourced comments suggest areas for extra diligence regarding implementation continuity and roadmap stability.

Opmed.ai has limited coverage on mainstream B2B software review platforms:

• G2 lists an entry with too few independent reviews to derive reliable buying insights.
• No visible Gartner Peer Insights product page was found during this research.
• TrustRadius and other mainstream review platforms showed little or no product review coverage for Opmed.ai.

Because of the limited density of independent end-user reviews, the publicly available perspectives in this section derive from:

• Vendor-published testimonials on Opmed.ai’s site (marketing-selected content)
• Health system press releases that quote partner representatives (PR-oriented statements)
• Employee reviews on Glassdoor (useful for organizational signals but not a substitute for customer outcomes)

• The vendor’s site highlights a testimonial attributed to Geisinger leadership describing positive operational changes and referencing progress within a short timeframe.
• Geisinger’s partner announcement states early indicators of improvement and describes intended use cases such as daily case and block optimization and multi-site load balancing.

These statements are partner announcements or vendor-published testimonials rather than independent, third-party validated outcome studies.

Public employee reviews on Glassdoor include criticisms that are relevant to buyer due diligence (these reflect employee perspectives, not customer experiences):

• Several reviews allege poor work/life balance and organizational disorganization.
• Other reviews report frequent strategic changes and management practices that may affect continuity.

Such employee-sourced comments should be considered as potential risk indicators for implementation capacity and ongoing support, and validated during vendor reference checks.

The vendor published a case narrative reporting reductions in weekly prediction error and estimated annualized revenue/cost impacts per OR. Key reported figures included reductions in prediction error and estimates of annualized underutilized time, with reconstructed financial impact estimates.

Critical evaluation:

• These figures are vendor-published and lack independent verification in the public domain.
• Some reported operational metrics (for example, staff FTE equivalents) require clearer unit definitions and calculation details for procurement evaluation.
• Buyers should request underlying calculations and replicate the vendor’s methodology against local data during a pilot.

A partner announcement described deployment goals including daily case and block optimization, multi-site load balancing, and improved staff utilization. The announcement indicated initial positive indicators but did not provide quantified before/after KPIs.

Critical evaluation:

• This is a partner announcement rather than an independent outcomes study and therefore does not constitute rigorous validation of long-term impact.
• Procurement teams should seek measurable pilot objectives and documented outcomes when using such announcements as evidence.

Opmed.ai is a healthcare operations optimization platform focused primarily on perioperative/operating room (OR) scheduling and related resource planning. The product uses machine learning and optimization algorithms to:

• Predict case durations and identify scheduling gaps (often described as “white space”)
• Generate recommendations for daily case and block schedules
• Support multi-site capacity balancing (shifting capacity across facilities)
• Recommend staffing levels based on predicted demand
• Apply similar optimization approaches in adjacent areas (e.g., procedural areas/NORA and rehab scheduling)

Opmed’s website describes the platform as supporting planning for cases, blocks, staff, equipment, PACU, ORs, sites, and rehab. The product suite is presented under names such as Opmed OR, Opmed Procedure, Opmed Resources, and a conversational assistant described by the vendor as a co‑pilot.